Collaboration - August 6, 2015
Sprint Bioscience enters into collaboration with Bayer HealthCare
Sprint Bioscience AB and Bayer HealthCare have entered into a collaboration and license agreement for the research, development, and commercialization of oncological drug candidates. Under the agreement, Sprint Bioscience licenses an early-stage inhibitor program targeting tumor metabolism to Bayer. Subsequently, Bayer will have full control over further development and worldwide commercialization rights for potential cancer therapeutics […]
Collaboration - May 11, 2015
Pelago, OmicScouts Collaborate
Pelago Bioscience AB and OmicScouts GmbH launched a commercial and scientific collaboration involving the use of the Cellular Thermal Shift Assay (CETSA™) for determination and quantification of drug-target interactions, according to BioSpace.com. Under the agreement, Pelago Bioscience grants OmicScouts use licenses to the CETSA method for mass spectrometric and proteomic applications for contract research projects […]
Collaboration - April 15, 2015
LDC, Astra Expand Alliance
The Lead Discovery Center GmbH (LDC) and AstraZeneca have expanded their alliance to discover new medicines for the treatment of diseases with high unmet medical need, according to report published on BioSpace.com. Through an additional three-year period of collaboration, AstraZeneca expects to provide an extended set of high-quality compounds to the LDC’s internal screening collection […]
Collaboration - December 15, 2014
Genmab Earns Milestone Fee
Genmab A/S announced it has reached a milestone in its DuoBody technology platform collaboration with Janssen Biotech, Inc., triggering a $3 million payment. The milestone payment is for pre-clinical progress with a DuoBody product candidate targeting cancer. “This milestone marks further progress in our DuoBody collaboration with Janssen. There are now 10 bispecific antibody programs […]
Collaboration - October 22, 2013
AstraZeneca and Evotec launche research collaboration
AstraZeneca and Evotec have launched a research collaboration focused on developing new drugs for kidney disease, the second partnership involving entities of the pharma giant and the German drug discovery alliance and development partnership company. The value of the collaboration was not disclosed. Evotec will license a series of molecules identified by its own drug-discovery […]
